<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=us-ascii"><meta name=Generator content="Microsoft Word 12 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:Wingdings;
panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
{font-family:Verdana;
panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
{font-family:"Comic Sans MS";
panose-1:3 15 7 2 3 3 2 2 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
{mso-style-priority:99;
mso-style-link:"Balloon Text Char";
margin:0cm;
margin-bottom:.0001pt;
font-size:8.0pt;
font-family:"Tahoma","sans-serif";}
p.MsoNoSpacing, li.MsoNoSpacing, div.MsoNoSpacing
{mso-style-priority:1;
margin:0cm;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";}
span.BalloonTextChar
{mso-style-name:"Balloon Text Char";
mso-style-priority:99;
mso-style-link:"Balloon Text";
font-family:"Tahoma","sans-serif";}
span.EmailStyle20
{mso-style-type:personal;
font-family:"Verdana","sans-serif";
color:windowtext;}
span.EmailStyle21
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1029" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-CA link=blue vlink=purple><div class=WordSection1><p class=MsoNormal><span style='color:#1F497D'>Hi all:<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>See below for the Oakville/Mississauga February support group meeting.<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Thx.<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Glen<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><div><div style='border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0cm 0cm 0cm'><p class=MsoNormal><b><span lang=EN-US style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'>From:</span></b><span lang=EN-US style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'> Walter Eadie [mailto:walter.eadie@cogeco.ca] <br><b>Sent:</b> February 13, 2019 3:51 PM<br><b>To:</b> PC Support Group<br><b>Subject:</b> February PC Support Group Meeting <o:p></o:p></span></p></div></div><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'> <o:p></o:p></span></p><p class=MsoNormal><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
<v:stroke joinstyle="miter" />
<v:formulas>
<v:f eqn="if lineDrawn pixelLineWidth 0" />
<v:f eqn="sum @0 1 0" />
<v:f eqn="sum 0 0 @1" />
<v:f eqn="prod @2 1 2" />
<v:f eqn="prod @3 21600 pixelWidth" />
<v:f eqn="prod @3 21600 pixelHeight" />
<v:f eqn="sum @0 0 1" />
<v:f eqn="prod @6 1 2" />
<v:f eqn="prod @7 21600 pixelWidth" />
<v:f eqn="sum @8 21600 0" />
<v:f eqn="prod @7 21600 pixelHeight" />
<v:f eqn="sum @10 21600 0" />
</v:formulas>
<v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect" />
<o:lock v:ext="edit" aspectratio="t" />
</v:shapetype><v:shape id="_x0000_s1027" type="#_x0000_t75" alt="Check out our website at https://www.pccn-oakville-mississauga.com/
" href="https://www.pccn-oakville-mississauga.com/" style='position:absolute;margin-left:197.6pt;margin-top:40.7pt;width:382.5pt;height:29.25pt;z-index:251661312;visibility:visible;mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;mso-position-horizontal-relative:text;mso-position-vertical:absolute;mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;mso-height-relative:margin' o:button="t">
<v:imagedata src="cid:image001.emz@01D4C478.C3A754F0" o:title="" />
</v:shape><![endif]--><![if !vml]><span style='mso-ignore:vglayout;position:absolute;z-index:251661312;margin-left:263px;margin-top:54px;width:510px;height:39px'><a href="https://www.pccn-oakville-mississauga.com/"><img border=0 width=510 height=39 src="cid:image004.png@01D4C478.C3A754F0" alt="Check out our website at https://www.pccn-oakville-mississauga.com/
" v:shapes="_x0000_s1027"></a></span><![endif]><!--[if gte vml 1]><v:shape id="_x0000_s1026" type="#_x0000_t75" alt="SUPPORT GROUP MEETING REMINDER" style='position:absolute;margin-left:162.2pt;margin-top:12.1pt;width:453pt;height:36.25pt;z-index:251659264;visibility:visible;mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;mso-position-horizontal-relative:text;mso-position-vertical:absolute;mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;mso-height-relative:margin' o:allowincell="f">
<v:imagedata src="cid:image011.emz@01D4C478.C3A754F0" o:title="" />
</v:shape><![endif]--><![if !vml]><span style='mso-ignore:vglayout;position:absolute;z-index:251659264;margin-left:216px;margin-top:16px;width:604px;height:48px'><img width=604 height=48 src="cid:image012.png@01D4C478.C3A754F0" alt="SUPPORT GROUP MEETING REMINDER" v:shapes="_x0000_s1026"></span><![endif]><b><span lang=EN-US><img width=161 height=99 id="Picture_x0020_5" src="cid:image003.jpg@01D4A7A6.07E62500" alt="cid:image001.jpg@01CDF27E.DB1D8B40"></span></b><span lang=EN-US><o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US> </span><b><span lang=EN-US style='font-family:"Comic Sans MS"'><o:p></o:p></span></b></p><p class=MsoNormal><!--[if gte vml 1]><v:shape id="_x0000_s1028" type="#_x0000_t75" alt="Our next meeting (always the 3rd Wednesday, 7pm at 2545 Sixth Line, Oakville) " style='position:absolute;margin-left:131.75pt;margin-top:1.35pt;width:596.35pt;height:24.75pt;z-index:251663360;visibility:visible;mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;mso-position-horizontal-relative:text;mso-position-vertical:absolute;mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;mso-height-relative:margin'>
<v:imagedata src="cid:image013.emz@01D4C478.C3A754F0" o:title="" />
</v:shape><![endif]--><![if !vml]><span style='mso-ignore:vglayout;position:absolute;z-index:251663360;margin-left:176px;margin-top:2px;width:795px;height:33px'><img width=795 height=33 src="cid:image014.png@01D4C478.C3A754F0" alt="Our next meeting (always the 3rd Wednesday, 7pm at 2545 Sixth Line, Oakville) " v:shapes="_x0000_s1028"></span><![endif]><span lang=EN-US><img width=160 height=34 id="Picture_x0020_2" src="cid:image010.png@01D4C3B3.E0ED7E10" alt="https://files.constantcontact.com/14b9ee0c501/1fd35007-cc89-46c2-b21b-1d880c92aee2.png"><o:p></o:p></span></p><p class=MsoNormal style='margin-left:288.0pt;text-indent:36.0pt'><span lang=EN-US style='font-size:14.0pt;font-family:"Verdana","sans-serif"'>is</span><b><span lang=EN-US style='font-size:18.0pt;font-family:"Verdana","sans-serif"'> FEBRUARY 20<sup>th</sup></span></b><span lang=EN-US><o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'>Last month I highlighted our new Support Group sponsor, <b>Astellas Pharma Canada</b>.<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'>This month, our guest speaker will be <b>Jennifer Kitchen</b>, Patient Access Manager - Ontario, for Astellas Pharma.<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'>Jennifer’s presentation will help us understand the drug approval and access process in Canada and Ontario.<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'>This is really important for all men who are on, or may be on in the future, some form of drug therapy such as hormones (ADT) or the other newer prostate cancer drugs.<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'>We read about FDA approvals and Health Canada approvals. We get surveys from Prostate Cancer Canada asking for patient input to the pan-Canadian Oncology Drug Review process. How does all this work and come together to get new PC drugs into general use?<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'>Even if it’s approved, is a new drug covered under the Ontario Drug Benefit Plan? If not, what is it going to cost?<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'>What is the Exceptional Access Program and how can that help? What about Clinical Trials? What about generic versions?<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'>Astellas Pharma Canada is the Canadian distributor for Xtandi (enzalutamide) but this is NOT a promotion session for this drug nor is it a technical session on how these drugs work. It is general education for us on approvals and access for the PC drugs which are now coming down the pipeline at an ever increasing rate. This should equip you to ask better questions when you next visit your doctor or oncologist.<o:p></o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'>I urge everyone to attend and look forward to seeing you next week.<br>(The good news is that next week’s weather looks a lot better than this week’s </span><span lang=EN-US style='font-size:12.0pt;font-family:Wingdings'>J</span><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'>)<o:p></o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'>Walter<o:p></o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;margin-left:36.0pt;text-indent:-36.0pt'><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'>P.S. If you happen to be lucky enough to be reading this on the Gulf Coast of Florida, <br>note this interesting PC Conference in Fort Meyers on March 2rd</span><span lang=EN-US> <br></span><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'><a href="https://www.eventbrite.com/e/prostate-cancer-today-living-well-choosing-wisely-florida-2019-tickets-52284835350">https://www.eventbrite.com/e/prostate-cancer-today-living-well-choosing-wisely-florida-2019-tickets-52284835350</a><o:p></o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;margin-bottom:12.0pt;margin-left:36.0pt;text-indent:-36.0pt'><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'> <o:p></o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%'><tr style='height:17.25pt'><td width=274 valign=top style='width:205.5pt;padding:2.25pt 2.25pt 2.25pt 2.25pt;height:17.25pt'></td></tr></table><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US><o:p> </o:p></span></p></div></body></html>